Machine Learning Prediction of Financial Toxicity in Patients with Resected Lung Cancer.

Journal: Journal of the American College of Surgeons
Published Date:

Abstract

BACKGROUND: Financial toxicity (FT) refers to the financial stress and detrimental impact on quality of life experienced by patients due to treatment cost. In patients with resected lung cancer (LC), we sought to identify those at risk of developing moderate or severe ("major") FT using machine learning (ML) techniques based on preoperative characteristics.

Authors

  • Nathaniel Deboever
    From the Departments of Thoracic and Cardiovascular Surgery (Deboever, Eisenberg, Antonoff, Hofstetter, Mehran, Rice, Roth, Swisher, Vaporciyan, Walsh, Rajaram), University of Texas MD Anderson Cancer Center, Houston, TX.
  • Qasem Al-Tashi
    Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Michael Eisenberg
    Department of Urology, Stanford University School of Medicine, Stanford, CA 94305, USA.
  • Maliazurina B Saad
    Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Mara B Antonoff
    Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: mbantonoff@mdanderson.org.
  • Wayne L Hofstetter
    Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Reza J Mehran
    Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • David C Rice
    Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Jack Roth
    From the Departments of Thoracic and Cardiovascular Surgery (Deboever, Eisenberg, Antonoff, Hofstetter, Mehran, Rice, Roth, Swisher, Vaporciyan, Walsh, Rajaram), University of Texas MD Anderson Cancer Center, Houston, TX.
  • Stephen G Swisher
    Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ara A Vaporciyan
    Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Garrett L Walsh
    Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Jia Wu
  • Ravi Rajaram
    Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX.